CEP
KYNB

Chicago Equity Partners’s Kyntra Bio KYNB Stock Holding History

Chicago Equity Partners’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$244K Sell
281
-1,077
-79% -$1.07M 0.02% 569
2019
Q4 		$1.46M Sell
1,358
-1,193
-47% -$1.22M 0.08% 358
2019
Q3 		$2.36M Sell
2,551
-12
-0.5% -$13.2K 0.11% 271
2019
Q2 		$2.9M Sell
2,563
-46
-2% -$50.3K 0.13% 226
2019
Q1 		$3.55M Sell
2,609
-52
-2% -$70.5K 0.14% 208
2018
Q4 		$3.08M Buy
+2,661
New +$2.99M 0.12% 235

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chicago Equity Partners's KYNB Position: Q1 2020 in Review

Chicago Equity Partners reduced its Kyntra Bio (KYNB) stake by 79% in Q1 2020, selling an estimated $1.07M and leaving 281 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #569.

Chicago Equity Partners first reported a position in KYNB in Q4 2018 and has held it in 6 quarters since. The position peaked at $3.55M in Q1 2019. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • Chicago Equity Partners held 281 shares of Kyntra Bio worth $244K as of Q1 2020.
  • Chicago Equity Partners sold 1,077 Kyntra Bio shares in Q1 2020, an estimated $1.07M.
  • Kyntra Bio made up 0.02% of Chicago Equity Partners's portfolio in Q1 2020, its #569 holding.
  • Chicago Equity Partners first reported a position in Kyntra Bio in Q4 2018 and has held it in 6 quarters since.
  • Chicago Equity Partners's Kyntra Bio position peaked at $3.55M in Q1 2019.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.